Vitruvian Shield, based at the Biopôle campus in Épalinges, builds an AI-native clinical evidence platform for hybrid trials and post-market surveillance. The platform brings together enrolment, electronic consent, patient-reported outcomes and data from wearables and connected devices in one audit-ready record, so that part of a clinical study can be run from patients’ homes, and generates the regulatory documents that sponsors and medical-device makers need, such as post-market clinical follow-up reports. It works alongside the systems of sponsors, contract research organisations and hospitals, in Switzerland and across Europe.